“Once-daily Roflumilast Cream 0.05% for the Treatment of Atopic Dermatitis in Patients Aged 2–5 Years With Diverse Skin Types: Subgroup Analysis From the Phase 3 INTEGUMENT-PED Trial”, J of Skin, vol. 10, no. 2, p. s745, Mar. 2026, doi: 10.25251/32bs1796.